Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

DuPont says strong dollar to have bigger impact than expected

Published 04/21/2015, 08:05 AM
Updated 04/21/2015, 08:05 AM
© Reuters. A view of the Dupont logo on a train car at the Dupont  Edge Moor  facility near Wilmington, Delaware

(Reuters) - Chemical maker DuPont (N:DD) reported lower sales in all of its businesses and said a strong dollar would take a bigger toll on its full-year earnings than it had expected.

The company's shares were down 1.6 percent at $71.66 in light trading before the bell.

Dupont, which receives 60 percent of sales from outside the United States, said it expects a strong dollar to reduce its 2015 profit by 80 cents per share, higher than its earlier forecast of 60 cents.

The company said it expects full-year operating earnings to be at the low end of its forecast of $4.00-$4.20 per share.

DuPont is targeting annual cost cuts of $1 billion and expects the savings to add 40 cents per share to 2015 profit.

The company expects to meet two-thirds of its cost savings target from work force reductions and the remaining from streamlining its asset base by consolidating facilities, or outsourcing some services.

Cost cuts added 10 cents to DuPont's operating profit in the quarter ended March 31, helping mitigate the impact of a 10 percent fall in agriculture sales, the company's biggest unit.

The company, which is locked in a proxy battle with activist investor Nelson Peltz, also raised its quarterly dividend to 49 cents per share from 47 cents on Tuesday.

DuPont is only days away from a shareholder vote which will decide if Peltz will get the four board seats he has been campaigning for. The company's shareholder meeting will be held on May 13.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Peltz has criticized DuPont for missing earnings expectations, among other things. The activist investor wants DuPont to separate its materials businesses from its nutrition and health, agriculture, and industrial biosciences divisions.

DuPont, which is in the process of spinning off its performance chemicals unit, has rejected the demand.

The spinoff of the company, named Chemours, was on track for the middle of this year, DuPont said on Tuesday.

Net income attributable to DuPont fell 28 percent to $1.03 billion, or $1.13 per share, while sales fell 9 percent to $9.17 billion. Excluding items, the profit was $1.34 per share.

Analysts on average expected a profit of $1.31 per share on revenue of $9.41 billion, according to Thomson Reuters I/B/E/S.

DuPont's shares closed at $72.84 on the New York Stock Exchange on Monday. They have risen 9 percent in the last 12 months.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.